| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014169140 |
| P356 | DOI | 10.1186/S41232-016-0022-5 |
| P932 | PMC publication ID | 5725797 |
| P698 | PubMed publication ID | 29259690 |
| P2093 | author name string | Masahiro Akishita | |
| Sumito Ogawa | |||
| Mitsutaka Yakabe | |||
| P2860 | cites work | Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People | Q24633789 |
| An overview of sarcopenia: facts and numbers on prevalence and clinical impact | Q24633887 | ||
| Tumor necrosis factor-α and muscle wasting: a cellular perspective | Q24806646 | ||
| Determinants of Muscle and Bone Aging | Q26998480 | ||
| Inflamm-aging. An evolutionary perspective on immunosenescence | Q28141817 | ||
| Invited review: Aging and sarcopenia | Q28206542 | ||
| Epidemiology of Sarcopenia among the Elderly in New Mexico | Q28268502 | ||
| Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin-6 Serum Levels | Q29040972 | ||
| The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates | Q30576350 | ||
| Sarcopenia: etiology, clinical consequences, intervention, and assessment. | Q33706637 | ||
| Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANTI study | Q33905135 | ||
| Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases | Q34040980 | ||
| Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study | Q34126129 | ||
| Clinical definition of sarcopenia | Q34457203 | ||
| Regulation of muscle protein synthesis during sepsis and inflammation | Q34628735 | ||
| Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration | Q35112511 | ||
| Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia | Q36039024 | ||
| Inflammaging decreases adaptive and innate immune responses in mice and humans | Q36225887 | ||
| Interleukin-6 in aging and chronic disease: a magnificent pathway | Q36518670 | ||
| Interleukin-6 in acute exercise and training: what is the biological relevance? | Q36698351 | ||
| Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass | Q36749035 | ||
| The immune system in extreme longevity | Q36942814 | ||
| IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting | Q37123224 | ||
| Sarcopenia: definition, epidemiology, and pathophysiology | Q37191762 | ||
| Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice | Q37351404 | ||
| Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength | Q37381535 | ||
| Oxidative stress, inflamm-aging and immunosenescence | Q37896272 | ||
| Consequences of sarcopenia. | Q37913616 | ||
| Sarcopenia in the elderly: diagnosis, physiopathology and treatment. | Q37966239 | ||
| Sarcopenia in the elderly | Q37991671 | ||
| The immune system and aging: a review. | Q38161967 | ||
| Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia | Q38181647 | ||
| Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization | Q40591215 | ||
| Serum IL-6 level and the development of disability in older persons | Q40809943 | ||
| Sarcopenia and age-related changes in body composition and functional capacity | Q40873939 | ||
| Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway | Q41249327 | ||
| Sarcopenia: origins and clinical relevance | Q41481490 | ||
| Role and potential mechanisms of anabolic resistance in sarcopenia | Q41955962 | ||
| TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A | Q42117099 | ||
| Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study | Q44107835 | ||
| Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments | Q44108448 | ||
| Effect of inflammation on handgrip strength in the non-critically ill is independent from age, gender and body composition | Q44673394 | ||
| Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people | Q46184923 | ||
| Inflammatory markers and physical performance in older persons: the InCHIANTI study | Q47925065 | ||
| Persistent changes in interleukin-6 and lower extremity function following hip fracture | Q51929760 | ||
| Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. | Q51993068 | ||
| Inflammation and frailty in older women | Q53549699 | ||
| Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. | Q54529003 | ||
| Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. | Q55035867 | ||
| Strength of Isometric and Isokinetic Contractions | Q57562892 | ||
| Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr | Q57717731 | ||
| Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes | Q59326276 | ||
| Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength | Q60298077 | ||
| Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans | Q61788681 | ||
| Age-related differences in knee muscle strength in normal women | Q70090975 | ||
| Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons | Q78483448 | ||
| Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure | Q80384354 | ||
| High innate production capacity of tumor necrosis factor-alpha and decline of handgrip strength in old age | Q80832901 | ||
| The origins of age-related proinflammatory state | Q81079607 | ||
| Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients | Q81698243 | ||
| Exercise, body composition, and functional ability: a randomized controlled trial | Q82975153 | ||
| Sarcopenia | Q84290662 | ||
| Association between sarcopenia and mortality in healthy older people | Q84358198 | ||
| [Transdisciplinary Approach for Sarcopenia. Sarcopenia : definition and the criteria for Asian elderly people] | Q85649968 | ||
| P921 | main subject | pathophysiology | Q1135939 |
| sarcopenia | Q1787939 | ||
| P304 | page(s) | 17 | |
| P577 | publication date | 2016-09-07 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Inflammation and Regeneration | Q27723951 |
| P1476 | title | Age-related sarcopenia and its pathophysiological bases | |
| P478 | volume | 36 |
| Q90318779 | Association between tongue pressure and subclinical carotid atherosclerosis in relation to platelet levels in hypertensive elderly men: a cross-sectional study |
| Q64057433 | Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus |
| Q47274750 | Canadine from Corydalis turtschaninovii Stimulates Myoblast Differentiation and Protects against Myotube Atrophy |
| Q91899809 | Coding Cell Identity of Human Skeletal Muscle Progenitor Cells Using Cell Surface Markers: Current Status and Remaining Challenges for Characterization and Isolation |
| Q92815610 | Potential Role of Tocotrienols on Non-Communicable Diseases: A Review of Current Evidence |
| Q93146669 | Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta-analysis |
| Q55022891 | Sarcopenia: assessment of disease burden and strategies to improve outcomes. |
| Q92860246 | Variables Influencing the Effectiveness of Creatine Supplementation as a Therapeutic Intervention for Sarcopenia |
Search more.